BioRestorative Historical Income Statement

BRTX Stock

USD 1.47 0.02 1.34%

Historical analysis of BioRestorative Therapies income statement accounts such as Selling General Administrative of 7.4 M, Depreciation And Amortization of 177.8 K or Selling And Marketing Expenses of 152.6 K can show how well BioRestorative Therapies performed in making a profits. Evaluating BioRestorative Therapies income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of BioRestorative Therapies's future profits or losses.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining BioRestorative Therapies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BioRestorative Therapies is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

About BioRestorative Income Statement Analysis

BioRestorative Therapies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to BioRestorative Therapies shareholders. The income statement also shows BioRestorative investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

BioRestorative Therapies Income Statement Chart

At this time, BioRestorative Therapies' Depreciation And Amortization is fairly stable compared to the past year. Research Development is likely to rise to about 4.2 M in 2024, whereas Interest Expense is likely to drop slightly above 12.7 K in 2024.

Selling General Administrative Selling And Marketing Expenses Other Operating Expenses Research Development

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of BioRestorative Therapies. It is also known as BioRestorative Therapies overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from BioRestorative Therapies' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into BioRestorative Therapies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.At this time, BioRestorative Therapies' Depreciation And Amortization is fairly stable compared to the past year. Research Development is likely to rise to about 4.2 M in 2024, whereas Interest Expense is likely to drop slightly above 12.7 K in 2024.

BioRestorative Therapies income statement Correlations

	Interest Expense	Selling General Administrative	Depreciation And Amortization	Selling And Marketing Expenses	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Total Revenue	Gross Profit	Cost Of Revenue	Net Income From Continuing Ops	Net Interest Income	Reconciled Depreciation	Non Operating Income Net Other
Interest Expense		0.09	0.49	0.53	0.06	-0.02	-0.11	-0.19	-0.11	0.06	-0.32	-0.52	-0.4	-0.15	-0.11	0.08	0.08	-0.24	-0.98	-0.04	-0.27
Selling General Administrative	0.09		0.27	-0.14	0.99	-0.97	-0.94	0.25	-0.94	0.99	-0.93	-0.39	-0.91	-0.83	-0.07	-0.58	0.45	-0.94	0.01	-0.7	0.17
Depreciation And Amortization	0.49	0.27		0.2	0.32	-0.31	-0.35	0.41	-0.34	0.32	-0.35	-0.21	-0.43	-0.17	0.16	0.2	0.07	-0.32	-0.38	-0.09	0.04
Selling And Marketing Expenses	0.53	-0.14	0.2		-0.08	0.08	0.12	0.23	0.12	-0.08	0.18	0.3	0.07	0.28	0.19	0.24	0.03	0.15	-0.52	0.2	0.15
Other Operating Expenses	0.06	0.99	0.32	-0.08		-0.98	-0.95	0.38	-0.95	1.0	-0.88	-0.28	-0.88	-0.76	-0.02	-0.56	0.49	-0.91	0.06	-0.7	0.26
Operating Income	-0.02	-0.97	-0.31	0.08	-0.98		0.96	-0.46	0.96	-0.98	0.86	0.22	0.86	0.74	0.05	0.59	-0.47	0.91	-0.11	0.75	-0.33
Ebit	-0.11	-0.94	-0.35	0.12	-0.95	0.96		-0.43	1.0	-0.95	0.9	0.33	0.93	0.73	0.07	0.58	-0.54	0.93	-0.03	0.87	-0.31
Research Development	-0.19	0.25	0.41	0.23	0.38	-0.46	-0.43		-0.42	0.38	-0.04	0.56	-0.17	0.18	0.2	-0.11	0.33	-0.15	0.35	-0.35	0.65
Ebitda	-0.11	-0.94	-0.34	0.12	-0.95	0.96	1.0	-0.42		-0.95	0.89	0.33	0.93	0.73	0.07	0.58	-0.55	0.93	-0.04	0.87	-0.31
Total Operating Expenses	0.06	0.99	0.32	-0.08	1.0	-0.98	-0.95	0.38	-0.95		-0.88	-0.28	-0.88	-0.76	-0.03	-0.57	0.48	-0.91	0.06	-0.71	0.26
Income Before Tax	-0.32	-0.93	-0.35	0.18	-0.88	0.86	0.9	-0.04	0.89	-0.88		0.68	0.97	0.91	0.11	0.5	-0.43	0.98	0.24	0.71	0.04
Total Other Income Expense Net	-0.52	-0.39	-0.21	0.3	-0.28	0.22	0.33	0.56	0.33	-0.28	0.68		0.6	0.72	0.13	0.1	-0.17	0.58	0.55	0.29	0.41
Net Income	-0.4	-0.91	-0.43	0.07	-0.88	0.86	0.93	-0.17	0.93	-0.88	0.97	0.6		0.81	0.1	0.5	-0.51	0.95	0.29	0.78	0.0
Income Tax Expense	-0.15	-0.83	-0.17	0.28	-0.76	0.74	0.73	0.18	0.73	-0.76	0.91	0.72	0.81		0.12	0.44	-0.23	0.9	0.12	0.53	0.07
Total Revenue	-0.11	-0.07	0.16	0.19	-0.02	0.05	0.07	0.2	0.07	-0.03	0.11	0.13	0.1	0.12		0.77	0.6	0.13	0.06	0.15	0.01
Gross Profit	0.08	-0.58	0.2	0.24	-0.56	0.59	0.58	-0.11	0.58	-0.57	0.5	0.1	0.5	0.44	0.77		0.08	0.56	-0.17	0.59	-0.19
Cost Of Revenue	0.08	0.45	0.07	0.03	0.49	-0.47	-0.54	0.33	-0.55	0.48	-0.43	-0.17	-0.51	-0.23	0.6	0.08		-0.43	-0.04	-0.6	0.14
Net Income From Continuing Ops	-0.24	-0.94	-0.32	0.15	-0.91	0.91	0.93	-0.15	0.93	-0.91	0.98	0.58	0.95	0.9	0.13	0.56	-0.43		0.14	0.77	-0.15
Net Interest Income	-0.98	0.01	-0.38	-0.52	0.06	-0.11	-0.03	0.35	-0.04	0.06	0.24	0.55	0.29	0.12	0.06	-0.17	-0.04	0.14		-0.1	0.41
Reconciled Depreciation	-0.04	-0.7	-0.09	0.2	-0.7	0.75	0.87	-0.35	0.87	-0.71	0.71	0.29	0.78	0.53	0.15	0.59	-0.6	0.77	-0.1		-0.37
Non Operating Income Net Other	-0.27	0.17	0.04	0.15	0.26	-0.33	-0.31	0.65	-0.31	0.26	0.04	0.41	0.0	0.07	0.01	-0.19	0.14	-0.15	0.41	-0.37

Click cells to compare fundamentals

BioRestorative Therapies Account Relationship Matchups

BioRestorative Therapies income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	5.1M	1.6M	1.8M	11.7K	13.4K	12.7K
Selling General Administrative	6.5M	1.9M	25.6M	15.6M	11.2M	7.4M
Depreciation And Amortization	217.4K	152.0K	205.2K	120.5K	165.7K	177.8K
Selling And Marketing Expenses	321.3K	28.3K	12.3K	168.0K	193.2K	152.6K
Other Operating Expenses	8.6M	2.8M	26.4M	19.0M	15.4M	9.8M
Operating Income	(8.4M)	(2.8M)	(26.3M)	(19.0M)	(15.2M)	(14.5M)
Ebit	(9.5M)	(9.6M)	(26.4M)	(19.0M)	(15.2M)	(14.5M)
Research Development	1.7M	876.8K	729.1K	3.5M	4.0M	4.2M
Ebitda	(9.3M)	(9.5M)	(26.2M)	(18.9M)	(15.1M)	(14.3M)
Total Operating Expenses	8.6M	2.8M	26.4M	19.0M	15.4M	9.8M
Income Before Tax	(14.6M)	(11.3M)	(44.3M)	(18.5M)	(10.4M)	(10.9M)
Total Other Income Expense Net	(6.2M)	(8.5M)	(18.0M)	5.8M	4.8M	5.0M
Net Income	(14.6M)	(12.3M)	(29.9M)	(18.0M)	(10.4M)	(10.9M)
Total Revenue	130K	77K	46K	119.8K	145.8K	120.6K
Net Income From Continuing Ops	(14.6M)	(10.0M)	(44.3M)	(18.5M)	(15.9M)	(16.7M)
Net Income Applicable To Common Shares	(14.6M)	(11.3M)	(44.3M)	(18.5M)	(16.6M)	(17.5M)
Net Interest Income	(5.1M)	(1.6M)	(1.8M)	11.7K	292.2K	306.8K
Reconciled Depreciation	217.4K	121.4K	89.1K	120.5K	154.8K	137.5K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioRestorative Historical Income Statement

About BioRestorative Income Statement Analysis

BioRestorative Therapies Income Statement Chart

Other Operating Expenses

BioRestorative Therapies income statement Correlations

BioRestorative Therapies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioRestorative Therapies income statement Accounts

Also Currently Popular

Additional Tools for BioRestorative Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Other Operating Expenses	+ 0.99	Selling General Administrative
Total Operating Expenses	+ 0.99	Selling General Administrative
Net Income From Continuing Ops	+ 0.98	Income Before Tax
Net Income	+ 0.97	Income Before Tax

Total Operating Expenses	- 0.98	Operating Income
Operating Income	- 0.98	Other Operating Expenses
Net Interest Income	- 0.98	Interest Expense
Operating Income	- 0.97	Selling General Administrative
Total Operating Expenses	- 0.95	Ebitda
Total Operating Expenses	- 0.95	Ebit